The Healthcare Platform continues monitoring of medications of cardiology group as part of the Pharma Monitoring project.
Jointly with the Association of Young Financiers and Businessmen (AYFB), the Healthcare Platform has explored 19 medications and identified that in July, as compared to June, the price of medications of cardiology group has declined by 0.51% (-0.13 points).
The monitoring has showed that the price of 17 medications of cardiology groups has not changed month on month. The price of one medication has increased, while price of 3 medications has declined.
Prices of the following medications have changed:
- Indapamide / Arifon Retard (1.5mg, 30 pills)-15.9 GEL
- Perindopril Arginine + Indapamide / Noliprel Forte Arginin 5 mg+1.25mg-27.37 GEL.
The Healthcare Platform and AYFB continue monitoring of prices of medications of various groups and exploring upturn-downturn tendencies of medication prices on the pharmaceutical market.
As reported, based on high public interest and the existing social background in the country, the Healthcare Platform and AYFB started monitoring of medication prices on the pharmaceutical market in August 2015. To measure the pharmaceutical market prices, the group has developed the Panaskerteli Index to make monthly dynamics of medication prices in specific groups of most in-demand medications transparent and public.